AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $437,000 | +22.8% | 46,533 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $356,000 | +11.2% | 46,533 | -10.1% | 0.00% | 0.0% |
| Q1 2020 | $320,000 | -48.6% | 51,737 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $622,000 | +2.6% | 51,138 | -2.5% | 0.00% | 0.0% |
| Q3 2019 | $606,000 | +17.0% | 52,464 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $518,000 | -23.5% | 51,838 | -1.4% | 0.00% | 0.0% |
| Q1 2019 | $677,000 | -17.0% | 52,549 | -2.2% | 0.00% | -50.0% |
| Q4 2018 | $816,000 | -22.3% | 53,718 | +2.3% | 0.00% | 0.0% |
| Q3 2018 | $1,050,000 | +2.5% | 52,522 | -0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,024,000 | -4.7% | 52,525 | -1.5% | 0.00% | 0.0% |
| Q1 2018 | $1,074,000 | +46.5% | 53,301 | -3.6% | 0.00% | 0.0% |
| Q4 2017 | $733,000 | -29.7% | 55,293 | -2.1% | 0.00% | 0.0% |
| Q3 2017 | $1,042,000 | -8.8% | 56,498 | -9.1% | 0.00% | 0.0% |
| Q2 2017 | $1,143,000 | -26.3% | 62,128 | -9.6% | 0.00% | -33.3% |
| Q1 2017 | $1,550,000 | -38.1% | 68,728 | -4.4% | 0.00% | -40.0% |
| Q4 2016 | $2,503,000 | +38.3% | 71,928 | -2.6% | 0.01% | +25.0% |
| Q3 2016 | $1,810,000 | +3.5% | 73,828 | +1.0% | 0.00% | 0.0% |
| Q2 2016 | $1,749,000 | +2.3% | 73,128 | +0.1% | 0.00% | 0.0% |
| Q1 2016 | $1,710,000 | -11.4% | 73,078 | +14.3% | 0.00% | -20.0% |
| Q4 2015 | $1,930,000 | -22.7% | 63,920 | +1.7% | 0.01% | -28.6% |
| Q3 2015 | $2,498,000 | -35.1% | 62,865 | +12.7% | 0.01% | -22.2% |
| Q2 2015 | $3,851,000 | +47.4% | 55,765 | +16.7% | 0.01% | +50.0% |
| Q1 2015 | $2,612,000 | +49.9% | 47,784 | +16.9% | 0.01% | +50.0% |
| Q4 2014 | $1,742,000 | +35.0% | 40,884 | +1.2% | 0.00% | +33.3% |
| Q3 2014 | $1,290,000 | +55.8% | 40,411 | +1.1% | 0.00% | +50.0% |
| Q2 2014 | $828,000 | +9.5% | 39,981 | +2.3% | 0.00% | 0.0% |
| Q1 2014 | $756,000 | -20.3% | 39,081 | 0.0% | 0.00% | -33.3% |
| Q4 2013 | $948,000 | +13.8% | 39,081 | +0.8% | 0.00% | +50.0% |
| Q3 2013 | $833,000 | -0.5% | 38,781 | +3.2% | 0.00% | -33.3% |
| Q2 2013 | $837,000 | -5.5% | 37,596 | +1.2% | 0.00% | 0.0% |
| Q1 2013 | $886,000 | – | 37,165 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |